18βGA repressed androgenic and survival responses in prostate cancer cells by inducing tumor-suppressive miR-488 and transcriptional downregulation of AR via modulating E2F transcription factor 3 (E2F3)α and serum response factor (SRF) activity on the androgen receptor promoter [29]. Here, SRF is linked to prostate cancer.